Jazz Pharmaceuticals PLC (JAZZ) support and resistance · P/E 1988, rev $4.07B
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
This page maps Jazz Pharmaceuticals PLC (JAZZ) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new JAZZ 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the JAZZ quote page for the session range and the stock page for the full model.
Not investment advice.